GENOMICS
With just two manual touchpoints: one for setting up the automated sample purification run and the other for setting up automated library preparation, sequencing, analysis, and reporting on the sequencer – and a total of 20 minutes of hands-on time for the entire workflow – NGS has become almost as accessible as assays like PCR or IHC.
Doylestown Hospital Doylestown Hospital, founded more than 100 years ago and located 30 miles north of Philadelphia, provides a wide range of inpatient and outpatient hospital care, including advanced surgical procedures, comprehensive specialty services, and wellness-education programs. The 247- bed community teaching hospital has a medical staff of 600 providers in more than 50 specialties.
Its Cancer Institute is a Nationally
Accredited Community Cancer Center by the American College of Surgeons (ACoS) Commission on Cancer, offering access to outstanding specialists and advanced screening, diagnostics, treatment and professional supportive services. Doylestown Health officially joined the University of Pennsylvania Health System in 2025, strengthening the two organisations’ shared commitment to delivering the most advanced, convenient
and compassionate care to patients and families across Philadelphia’s northern suburbs. Doylestown Health and its affiliates will now be known as Penn Medicine Doylestown Health, bringing together one of the nation’s top academic health systems, world-renowned for its clinical and research excellence, with a regional health system known for clinical excellence and high-quality, compassionate care.
References 1 Hanuschak D, DePiero M, DeMoraes M,
et al. The impact of COVID-19 on patients diagnosed with melanoma, breast, and colorectal cancer. Am J Surg. 2024;229:36- 41. doi:10.1016/
j.amjsurg.2023.09.040
2 Sadik H, Pritchard D, Keeling DM, et al. Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non-Small- Cell Lung Cancer. JCO Precis Oncol. 2022;6:e2200246. doi:10.1200/ PO.22.00246
3 Scott JA, Lennerz J, Johnson ML, et al. Compromised Outcomes in Stage IV Non- Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO Oncol Pract. 2024;20(1):145-153. doi:10.1200/ OP.22.00611
Dr Allison Eck PhD HTL(ASCP)CM QLS AHI(AMT) is Director, Pathology and Laboratory Medicine at
Doylestown Health, which is now part of University of Pennsylvania
Health System (Penn Health).
Allison Eck is the lead histotechnologist at Doylestown Hospital in Pennsylvania. She has been a histotechnologist for 15 years after graduating with a degree in histotechnology from Harford Community College in Maryland and a bachelor’s degree in biology from Lycoming College in Pennsylvania. She holds her histotechnologist (HTL) and qualification in laboratory safety (QLS) certifications through the ASCP, as well as her Allied Health Instructor (AHI) certification through AMT. Allison has spoken at a variety of professional conferences on respiratory disease as well as laboratory safety and ergonomics.
www.doylestownhealth.org
To learn more about Thermo Fisher Scientific’s NGS portfolio visit the website.
www.thermofisher.com/uk/en/home/ brands/
ion-torrent.html
46
JUNE 2025
WWW.PATHOLOGYINPRACTICE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
